Company Description
DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific.
It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement.
The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research.
In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software.
DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.
| Country | United States |
| Founded | 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Jason Chen |
Contact Details
Address: 4 Embarcadero Center Suite 1449 San Francisco, California 94105 United States | |
| Phone | (614) 365-0143 |
| Website | dih.com |
Stock Details
| Ticker Symbol | DHAI |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001883788 |
| ISIN Number | US23290B1061 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Jason Chen | Founder, Chairman and Chief Executive Officer |
| Lynden Bass | Chief Financial Officer and Director |
| Patrick Bruno | CMO of Hospital and Clinic and Director |
| Slavko Skafar | Senior Vice President of? Sales ? EMEA Indirect? |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 15, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jul 15, 2024 | 8-K | Current Report |
| Jul 15, 2024 | 10-K | Annual Report |
| Jun 28, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Jun 27, 2024 | 8-K | Current Report |
| Jun 10, 2024 | D | Notice of Exempt Offering of Securities |
| Jun 7, 2024 | 8-K | Current Report |
| May 20, 2024 | 10-K/A | [Amend] Annual report |
| Apr 30, 2024 | 8-K | Current Report |
| Apr 30, 2024 | 8-K | Current Report |